{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Pharma 4.0: AI, Validation, and the Future of Life Sciences","description":"Step into the future of pharmaceutical and medical device innovation with Steve on The Life Science Effect. In this episode, Steve explores the transformative power of Pharma 4.0 and Validation 4.0, drawing insights from two thought-provoking blog posts by Robert Perks of Performance Validation. Discover how digital-first strategies, artificial intelligence, and continuous monitoring are reshaping compliance, quality assurance, and operational efficiency in life sciences. Steve breaks down the shift from paper-based systems to predictive analytics, highlighting the importance of aligning people, processes, and technology in a highly regulated industry. Whether you\u2019re a new entrepreneur, engineer, or project manager, you\u2019ll gain actionable takeaways on embracing digital transformation, collaborating with regulators, and staying ahead of industry trends. Tune in for key lessons, expert perspectives, and a call to action for leaders ready to drive change in pharma and medical devices. Keywords: Pharma 4.0, Validation 4.0, AI in life sciences, regulatory compliance, digital transformation.   BLOG POSTS MENTIONED: Embracing Pharma 4.0 \u2014 A Strategic Imperative for a Digital-First Future  - Performance Validation   The Transformative Impact of Artificial Intelligence on Validation in Life Sciences  - Performance Validation   MUSIC: Acid Jazz-Kevin MacLeod used under the Creative Commons Attribution 4.0 International License   TRANSCRIPT: 00:00:00 HOST: You are about to experience the Life Science Effect, Season 2, brought to you by our presenting sponsor, BPM Associates. 00:00:15 HOST: Extraordinary people. HOST: Relationships that matter. HOST: Important change for a better world. HOST: The joy of belonging. HOST: Life. Science. Leadership. 00:00:29 HOST (Steve): This is Steve, and it's time for another active ingredient. 00:00:33 HOST: I thought for a minute about not calling this segment "active ingredient" today because it's not just one article\u2014it's two blog posts. But it's still off the cuff. I\u2019ve read these two blog posts and I\u2019m going to interview myself about them. Both are from the website of a great company called Performance Validation. 00:00:54 HOST: Performance Validation is a compliance company. They do validation services, commissioning qualification, building commissioning, temperature mapping, computer system validation\u2014really involved in the nuts and bolts of our industry to ensure processes and equipment run in compliance. 00:01:24 HOST: They\u2019re a great company. Check them out at PERFVAL.com. 00:01:32 HOST: The two blog posts are by Robert Perks, Director of Digital Solutions for Performance Validation. I don\u2019t know Robert personally, but I really enjoyed these posts. Maybe I\u2019ll get to know him someday. 00:01:52 HOST: The first is \u201cEmbracing Pharma 4.0: A Strategic Imperative for a Digital First Future.\u201d The second is \u201cThe Transformative Impact of Artificial Intelligence on Validation in Life Sciences.\u201d 00:02:16 HOST: What caught my eye about these articles? If you heard a recent episode where I talked about Industry 4.0, you know I admitted I don\u2019t really know what I\u2019m talking about there. So these posts caught my eye\u2014maybe I can learn more about Industry 4.0 if Robert is talking about Pharma 4.0 validation. He even uses the term \u201cValidation 4.0\u201d in the AI article. 00:02:51 HOST: My first reaction was excitement. Pharma 4.0 aligns with Industry 4.0 by connecting resources, information, people, equipment, and software through digital systems. It aligns organizations, processes, and culture with emerging technology. 00:03:24 HOST: Pharma 4.0 is actually a trademarked term by ISPE\u2014the International Society for Pharmaceutical Engineering. They\u2019ve broadened their scope to include computer systems and medical devices, not just pharmaceuticals. 00:04:13 HOST: ISPE coined Pharma 4.0 to show how Industry 4.0 applies to pharmaceutical manufacturing, development, and distribution. At a high level, it\u2019s about aligning resources, systems, organizations, processes, and culture to fit our regulated environment, ensuring quality and compliance while breaking down silos and moving away from paper-based systems. 00:05:13 HOST: Now, we live in a paperless world. How do we align digitally enabled processes to take full advantage? 00:05:31 HOST: Is this a big deal or just noise? It\u2019s a big deal. Mr. Perks points out this isn\u2019t a future vision\u2014it\u2019s happening now. It reminds me of the late 90s when computer systems started replacing paper, and the FDA was asked how they\u2019d regulate digital records. 00:06:32 HOST: Now, there\u2019s more collaboration between regulators and industry, leading to optimal solutions. This is the right now, not just the future. 00:06:55 HOST: The second post is \u201cThe Transformative Impact of Artificial Intelligence on Validation in Life Sciences.\u201d So, what is validation? 00:07:09 HOST: Validation means proof that a medicine, device, or system is fit for its intended use. Proof is evidence\u2014often test results or measurements. 00:08:17 HOST: In pharma and medical devices, validation means proving the system, process, device, or medicine is fit for its intended use\u2014safe, effective, and reliable. 00:08:54 HOST: Historically, validation was retroactive: something happens, a report is written, signed, and filed until an auditor reviews it. If bad product was made, it might already be on the market, leading to recalls and potential harm. 00:09:54 HOST: With Validation 4.0, we\u2019re using AI and digital technologies for continuous monitoring and testing. AI can analyze data streams and alert us to issues before bad medicine is made\u2014predictive, not just reactive. 00:10:44 HOST: My company just brought on a new consultant with high-speed manufacturing experience. Life sciences often lag in adopting advanced manufacturing technologies, but Industry 4.0, Pharma 4.0, and now Validation 4.0 are being embraced. 00:11:23 HOST: This is the future\u2014and in some cases, it\u2019s today. The next four or five years will be transformative for our industry. I want my company at the forefront, so I\u2019m asking folks to read, listen, try things out, and embrace technology. 00:12:18 HOST: I\u2019d love to hear from others actually working in this space. Someone smarter than me might say it\u2019s easier than it looks, or that we could go faster if we removed obstacles. 00:12:39 HOST: Check out these blog posts\u2014I\u2019ll link them in the show notes. Let me know what you think. Is Robert Perks onto something? If you have questions or want to see something addressed, let me know. 00:13:00 HOST: As always, you can reach me at stephen.vincent@bpm-associates.com. Visit thelifescienceeffect.com. Find us on all podcast platforms. Like, subscribe, do all the internet things. Most importantly, take care of each other, stay strong, and thanks for listening. ","author_name":"The Life Science Effect","author_url":"http:\/\/www.thelifescienceeffect.com","html":"